Based on the above, we hypothesized that angiopoietin blockade would halt experimental mesothelioma progression in vivo by a) preventing a direct Ang-1-provoked growth effect on mesothelioma cells and b) inhibiting tumor angiogenesis. This evidence concerns the gene ANGPT1 and neoplasm.